Dr. Ebru Karasu

Dr. Ebru Karasu started working at Boehringer Ingelheim in May 2021 as the Head of Laboratory/Study Director. Prior to that, they worked as a Wissenschaftlicher Mitarbeiter at Universitätsklinikum Ulm (University Hospital Ulm) from April 2017 to March 2021.

Dr. Ebru Karasu completed a Bachelor's degree in Molecular Medicine from Ulm University in 2015. Dr. Ebru then pursued a Master's degree in Molecular Medicine from the same university, which was completed in 2017. Subsequently, they attended the International Graduate School in Molecular Medicine Ulm from 2017 until 2020, where they earned their Dr. rer.nat. degree in Molecular Medicine.